Clinical Trial: A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07226349) titled 'A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors' on Nov. 06.

Brief Summary: The purpose of this study is to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-75098 alone and in combination with BGB-43395 and fulvestrant in participants with advanced solid tumors.

Study Start Date: Dec. 02

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumor

Intervention: DRUG: BG-75098

Administered orally.

DRUG: BGB-43395

Administered orally.

DRUG: Fulvestrant

Administered by intramuscular injection.

Recruitment Status...